The immunodepressive and hematotoxic activities of N-trifluoro-acetyl-adriamycin-14-valerate.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D007166:Immunosuppressive Agents; D007939:Leukemia L1210 / Q000188:drug therapy; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D011135:Polysaccharides, Bacterial / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011135:Polysaccharides, Bacterial; C016163:valrubicin; D004317:Doxorubicin